Atlas Trials

Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C

Clinical trial NCT02971033 · TERMINATED

Trial details

NCT number
NCT02971033
Sponsor
VA Office of Research and Development
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2018-04-16
Primary completion
2021-03-31
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.